PowderMed
Navigation Links
PowderMed in Medical News
PowderMed Announces Needle-Less Flu Vaccine
... A British-based biotech firm called powdermed Ltd has announced that it has successfully tested a new experimental DNA va... the 36 volunteers. The study is published in the journal Vaccine. powdermed said that it would now conduct bigger tests for its vaccine. ...PowderMed in Biological Technology
...inical phase.
Simultaneously ITS has moved to strengthen its board and management team
with the appointment of Brenda Reynolds, a co-founder of powdermed (acquired
by Pfizer in 2006), as company director. Another seasoned vaccine industry
professional, Jill Makin, former VP of R&D for Emergent Bioso...
PowderMed in other areas
PowderMed was founded in May 2004 to develop the proprietary Particle Mediated ... In December 2008 the PowderMed site in Oxford was closed down, following the ...
Based on these results, PowderMed will start phase II studies using ... PowderMed also has a product for the treatment of ... PowderMed vaccines are delivered ...
... chronic pain drug, phillipine cone snail, pmed, powdermed, rehabilitation ... medication with a gun made by PowderMed in Oxford, England, and the drugs will ...
Based on these results, PowderMed will start phase II studies using ... PowderMed also has a product for the treatment of ... PowderMed vaccines are delivered ...
Powdermed PMED | Popular Science
Shots ... Powdermed PMED. Shots without needles. Posted 11.08.2005 at 3:00 ... PowderMed's new vaccine gun, the PMED, requires no sharps. The flashlight-shaped ...... chronic pain drug, phillipine cone snail, pmed, powdermed, rehabilitation ... medication with a gun made by PowderMed in Oxford, England, and the drugs will ...
PowderMed initiates a phase I clinical trial for a therapeutic Herpes ...
BioPortfolio the comprehensive website for data, information, search engine and services on biotechnology, pharmaceutical and healthcare research, companies and ...PowderMed says experimental DNA vaccine for flu successful : Health
WASHINGTON - Biotech firm PowderMed Ltd has announced that an experimental flu ... PowderMed scientists penned an article in the journal Vaccine detailing the ...Other TagsObturatorTierTierPasserAnchorsRevoRevoRevoRevoEmbolicOther Contentsfragmentfragmentfragmentfragmentfragmentfragmentfragmentfragmentrestrictionrestrictionrestrictionrestrictionrestrictionrestrictionrestrictionrestrictionribosomeribosomeribosomeribosomemetabolitemetabolitemetabolitemetabolitemetabolitemetabolitesecondarysecondarysecondarysecondarysecondarysecondarysecondarysecondarysecondarysecondarymessengermessengermessengermessengermessengermessenger
(Date:12/6/2009)... has become a mainstay of multiple myeloma treatment ... system of patients who have received stem cell ... early clinical trial results to be presented by ... American Society of Hematology,s (ASH) annual meeting on ... Convention Center, Room 243-245, 5:45 pm CT). , ...
(Date:12/6/2009)... by researchers from the Medical College of Wisconsin, in ... pain and other sickle cell disease complications in children. ... providers and patients were also identified. The study ... of pediatrics at the Medical College and Children,s Research ... presented at the American Society of Hematology meeting Dec. ...
(Date:12/6/2009)... 2009 A new study provides welcome news for ... thromboembolism (VTE). , The condition is estimated to ... occurs when an abnormal clot forms in a vein ... swelling. In some cases, the clot may detach from ... to the lungs, causing a potentially fatal condition known ...
(Date:12/5/2009)... combination has shown in a phase 1/2 clinical ... the treatment of patients newly diagnosed with multiple myeloma, ... say researchers from Dana-Farber Cancer Institute. , Partial responses ... patients treated with the drug combination in the multi-center ... response rate" in the phase 2 population, reports Paul ...
(Date:12/5/2009)... Blood Cancer Is Most Challenging-- ,, PHILADELPHIA ... identified specific genes, dubbed partner genes, that fuse with ... in infants. By more accurately defining specific partner genes, ... from particular treatments. ,, Oncologists also aim to ...
Breaking Medicine News(10 mins):Health News:Bortezomib shows promise in reducing GVHD and reconstituting immune system in some patients 2Health News:New study finds barriers to pain treatment in children with sickle cell disease 2Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4[0] Bortezomib shows promise in reducing GVHD and reconstituting immune system in some patients[1] New study finds barriers to pain treatment in children with sickle cell disease[0] New drug shows promise for those with clotting disorders: McMaster researcher[0] Multiple myeloma patients experience high response rate with new 3-drug combination[0] New Gene Findings Will Help Guide Treatment in Infant Leukemia
(Date:12/7/2009)... NY) Matthew Levy, Ph.D., assistant professor of ... Yeshiva University, has been awarded more than $700,000 ... high-risk/high-reward cancer research. Dr. Levy,s work will focus ... cells, thus eliminating or significantly reducing serious or ... is one of 13 young scientists nationwide selected ...
(Date:12/6/2009)... York, N.Y./Los Angeles, Calif.: Stand Up To Cancer ... to support high-risk/high-reward cancer research conducted by 13 young ... a total of up to $750,000 as part of ... generation of cancer research leaders. , "We asked our ... comfort zones and strive to make big differences with ...
(Date:12/6/2009)... Just three months after the Euro 5 Norm for ... models, researchers at the Technische Universitaet Muenchen (TUM) have ... the more stringent Euro 6 emissions standard. A research ... of Internal Combustion Engines has succeeded in reducing the ... TUM engineers have also developed a probe that allows ...
Breaking Biology News(10 mins):Einstein receives high-risk/high-reward cancer research funding 2Einstein receives high-risk/high-reward cancer research funding 3Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 2Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 3Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 4Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 5Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 6Munich lab demonstrates diesel truck engine with barely measurable emissions 2Munich lab demonstrates diesel truck engine with barely measurable emissions 3Saudi Arabia Expands Breast Cancer Awareness Programs 59598 1Paradigm shift needed to combat drug resistance 59596 1Paradigm shift needed to combat drug resistance 59596 2Research shows treating HIV AIDS with interleukin 2 is ineffective 10389 1Research shows treating HIV AIDS with interleukin 2 is ineffective 10389 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |